Professional
Added to YB: 2025-05-30
Pitch date: 2025-05-28
TEM [bearish]
Tempus AI, Inc.
+13.61%
current return
Author Info
Spruce Point Capital Management is an activist investment manager specializing in forensic short-selling. Sign up for the newsletter.
Company Info
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$8.4B
Pitch Price
$54.75
Price Target
21.30 (-55%)
Dividend
N/A
EV/EBITDA
-57.12
P/E
-33.40
EV/Sales
7.05
Sector
Life Sciences Tools and Services
Category
N/A
Spruce Point Capital Management Issues 'Strong Sell' Research Opinion On Tempus AI, Inc. (Nasdaq: TEM)
TEM: Founder Lefkofsky's history of overhyped IPOs raises red flags. Only 2% of revenue from AI despite rebranding. Multiple board members linked to accounting restatements. Suspicious Softbank JV, aggressive TCV reporting, related-party Pathos deal, and weakening AstraZeneca partnership. 77% of rev paid as stock comp with insiders selling. 50-60% downside vs 1% upside at $66.82 PT.
Read full article (8 min)